液相色谱-质谱/质谱联用法测定苯唑西林浓度及其胶囊剂人体生物等效性的研究

目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000 mg,采用蛋白沉淀法处理血浆样品,使用LC-MS/MS法测定血浆中苯唑西林的浓度,并以DAS 2.0软件进行方差分析及双单侧t检验,判断2种制剂是否具有生物等效性。结果:口服受试及参比制剂后,血浆中苯唑西林峰浓度(Cmax)分别为(17.0±2.77)、(15.5±3.46)μg/ml;达峰时间(tmax)分别为(0.63±0.14)、(0.72±0....

Full description

Saved in:
Bibliographic Details
Published in中国医院用药评价与分析 no. 5; pp. 597 - 600
Main Author 任进民 王川平 赵曦 董劼 朱辉梅
Format Journal Article
LanguageChinese
Published 河北医科大学第二医院药学部,河北石家庄,050000%石药集团中奇制药技术 石家庄 有限公司,河北石家庄,050051 2015
Subjects
Online AccessGet full text
ISSN1672-2124
DOI10.14009/j.issn.1672-2124.2015.05.014

Cover

Loading…
Abstract 目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000 mg,采用蛋白沉淀法处理血浆样品,使用LC-MS/MS法测定血浆中苯唑西林的浓度,并以DAS 2.0软件进行方差分析及双单侧t检验,判断2种制剂是否具有生物等效性。结果:口服受试及参比制剂后,血浆中苯唑西林峰浓度(Cmax)分别为(17.0±2.77)、(15.5±3.46)μg/ml;达峰时间(tmax)分别为(0.63±0.14)、(0.72±0.26)h;药时曲线下面积(AUC0~6 h)分别为(22.52±4.38)、(22.54±5.79)μg/(ml· h);受试制剂的相对生物利用度为(102.8±19.3)%。结论:受试制剂与市售参比制剂具有生物等效性。
AbstractList 目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000 mg,采用蛋白沉淀法处理血浆样品,使用LC-MS/MS法测定血浆中苯唑西林的浓度,并以DAS 2.0软件进行方差分析及双单侧t检验,判断2种制剂是否具有生物等效性。结果:口服受试及参比制剂后,血浆中苯唑西林峰浓度(Cmax)分别为(17.0±2.77)、(15.5±3.46)μg/ml;达峰时间(tmax)分别为(0.63±0.14)、(0.72±0.26)h;药时曲线下面积(AUC0~6 h)分别为(22.52±4.38)、(22.54±5.79)μg/(ml· h);受试制剂的相对生物利用度为(102.8±19.3)%。结论:受试制剂与市售参比制剂具有生物等效性。
R965; 目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000 mg,采用蛋白沉淀法处理血浆样品,使用LC-MS/MS法测定血浆中苯唑西林的浓度,并以DAS 2.0软件进行方差分析及双单侧t检验,判断2种制剂是否具有生物等效性。结果:口服受试及参比制剂后,血浆中苯唑西林峰浓度(Cmax)分别为(17.0±2.77)、(15.5±3.46)μg/ml;达峰时间(tmax)分别为(0.63±0.14)、(0.72±0.26)h;药时曲线下面积(AUC0~6 h)分别为(22.52±4.38)、(22.54±5.79)μg/(ml· h);受试制剂的相对生物利用度为(102.8±19.3)%。结论:受试制剂与市售参比制剂具有生物等效性。
Abstract_FL OBJECTIVE:To determine human plasma concentration of oxacillin by liquid chromatography -mass spectrometry ( LC-MS/MS ) and study the bioequivalence of the tested and the standard preparations of oxacillin sodium capsules.METHODS:In a randomized, single dose and double crossover design, 20 healthy male volunteers were administered orally with tested and reference oxcillin sodium capsules ( 1 000 mg ) .The plasma samples were treated by of protein precipitation method, and the plasma concentrations of oxacillin within 6 hours after administration were determined by LC-MS/MS;DAS 2.0 software was employed for analysis of variance and two one-sided t-test for evaluation of the bioequivalence of the two preparations.RESULTS: After oral administration of the tested vs. reference preparations, peak plasma concentration (Cmax) of oxacillin stood at (17.0 ±2.77) vs.(15.5 ±3.46) μg/ml, with tmax of (0.63 ±0.14) vs.(0.72 ±0.26) h, and area under the concentration-time curve (AUC0-6 h) of (22.52 ±4.38) vs.(22.54 ±5.79) μg/(ml· h).The relative bioavailability of the tested preparation was (102.8 ± 19.3)%.CONCLUSIONS:The tested oxacillin sodium capsules and the reference preparation are bioequivalent.
Author 任进民 王川平 赵曦 董劼 朱辉梅
AuthorAffiliation 河北医科大学第二医院药学部,河北石家庄050000 石药集团中奇制药技术石家庄有限公司,河北石家庄050051
AuthorAffiliation_xml – name: 河北医科大学第二医院药学部,河北石家庄,050000%石药集团中奇制药技术 石家庄 有限公司,河北石家庄,050051
Author_FL ZHAO Xi
DONG Jie
REN Jinmin
ZHU Huimei
WANG Chuanping
Author_FL_xml – sequence: 1
  fullname: REN Jinmin
– sequence: 2
  fullname: WANG Chuanping
– sequence: 3
  fullname: ZHAO Xi
– sequence: 4
  fullname: DONG Jie
– sequence: 5
  fullname: ZHU Huimei
Author_xml – sequence: 1
  fullname: 任进民 王川平 赵曦 董劼 朱辉梅
BookMark eNo9kEtLAlEUx-_CIDO_RNCume6de-fOuAzpBUIb9zJPm6FGc4iyVU9odCHhSKBQbSpd9LKUkKIv4zx2fYVuGB0O_A-H3_kf-M-AhFNyDADmEeQRgTCzaPOW6zo8opLACUggvACRyEPWiCRA8n8_DdKua6lQECUoCJgkgR0O-1HnPfb68fMLF791mXx_NCZDfORHfjd8bYWDevDYjutPgX8R336FV5fhoBmM7oJGLTgbxifDoFMLvOPxaDT-bEb-deT1ogcvbJ2Hh_dR-zS68aPecBZMmcqWa6T_NAXyK8v57BqX21hdzy7lOI0SwqkGVjSoY0yQppsZQnUlI6mEYqqKpkElFctIZSLLqmQSlVJF0wyqUcYJig4NnAILE9s9xTEVp1iwS7sVhz0sHBSrrMp21dz_zQeKLB2Gz01wbbPkFHcsdlCuWNtKpVqgVBRFJGOMfwCRrZMp
ClassificationCodes R965
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.14009/j.issn.1672-2124.2015.05.014
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Determiniation of Oxacillin Concentration in Healthy Volunteers by LC-MS/MS and Bioequivalence Study of Oxacillin Capsules in Human Body
DocumentTitle_FL Determiniation of Oxacillin Concentration in Healthy Volunteers by LC-MS/MS and Bioequivalence Study of Oxacillin Capsules in Human Body
EndPage 600
ExternalDocumentID zgyyyypjyfx201505014
665551833
GroupedDBID 2RA
92L
ALMA_UNASSIGNED_HOLDINGS
CDYEO
CQIGP
W91
~WA
2B.
4A8
92I
93N
ABDBF
ACUHS
EOJEC
OBODZ
PSX
TCJ
TUS
ID FETCH-LOGICAL-c644-be3ac0d3341cdf946da97b4636b5fe67b381b67b88b7f4b66acce6c66da2ad0e3
ISSN 1672-2124
IngestDate Thu May 29 04:11:26 EDT 2025
Wed Feb 14 10:30:15 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 5
Keywords LC-MS/MS
Oxacillin
Bioequivalence
液相色谱-质谱/质谱联用法
生物等效性
苯唑西林
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c644-be3ac0d3341cdf946da97b4636b5fe67b381b67b88b7f4b66acce6c66da2ad0e3
Notes Oxacillin;LC-MS/MS;Bioequivalence
REN Jinmin, WANG Chuanping, ZHAO Xi, DONG Jie, ZHU Huimei ( 1. Dept. of Pharmacy, The Second Hospital of Hebei Medical Unversity, Hebei Shijiazhuang 050000, China; 2. Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd. of Shijiazhuang Pharmaceutical Group, Hebei Shijiazhuang 050051, China)
OBJECTIVE:To determine human plasma concentration of oxacillin by liquid chromatography -mass spectrometry ( LC-MS/MS ) and study the bioequivalence of the tested and the standard preparations of oxacillin sodium capsules.METHODS:In a randomized, single dose and double crossover design, 20 healthy male volunteers were administered orally with tested and reference oxcillin sodium capsules ( 1 000 mg ) .The plasma samples were treated by of protein precipitation method, and the plasma concentrations of oxacillin within 6 hours after administration were determined by LC-MS/MS;DAS 2.0 software was employed for analysis of variance and two one-sided t-test for evaluation of the bioe
PageCount 4
ParticipantIDs wanfang_journals_zgyyyypjyfx201505014
chongqing_primary_665551833
PublicationCentury 2000
PublicationDate 2015
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – year: 2015
  text: 2015
PublicationDecade 2010
PublicationTitle 中国医院用药评价与分析
PublicationTitleAlternate Evaluation and Analysis of Drug-use in Hospitals of China
PublicationTitle_FL Evaluation and Analysis of Drug-Use in Hospitals of China
PublicationYear 2015
Publisher 河北医科大学第二医院药学部,河北石家庄,050000%石药集团中奇制药技术 石家庄 有限公司,河北石家庄,050051
Publisher_xml – name: 河北医科大学第二医院药学部,河北石家庄,050000%石药集团中奇制药技术 石家庄 有限公司,河北石家庄,050051
SSID ssib025702234
ssib017477209
ssib001103637
ssib051368574
ssib000405437
ssib001215202
ssib036441963
ssib006563103
ssib057928707
Score 1.9801582
Snippet 目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000...
R965; 目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 597
SubjectTerms 液相色谱-质谱/质谱联用法
生物等效性
苯唑西林
Title 液相色谱-质谱/质谱联用法测定苯唑西林浓度及其胶囊剂人体生物等效性的研究
URI http://lib.cqvip.com/qk/86765X/201505/665551833.html
https://d.wanfangdata.com.cn/periodical/zgyyyypjyfx201505014
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LahRBcIgJiBdRVHyTg31RJs7O9PPYvdlFBD1F0FPYeWzEw_qKoDn5BBMPIlkRFNSLmhx8myBB8Wfcx81fsKqnd3bERdRlmKntrq7ueuxM1Wx3tecdiqkMkjRL_JjxzKcig_ugoqkPzkemslTRmOHi5BMn-bFT9Phpdnps4nBp1tKV-XgqWRi5ruR_tAploFdcJfsPmi2IQgHAoF84g4bh_Fc6JjVODBwhqQmiDDGS1CSRypZIYgJiKr6FKNGyKCK1OjFVIuujqqB9hShqKeZV0EFEFLMAI9KQGiO6RpS2yIboOpYAsrLNNSOmjsgKcIRrpSLEMZpojgB0LbUFGDKAdCILMGTDVSkigQ2KreBAYNrSsQNTdQQARysE9DTC2Ck0tGOWAdHCImsiLTs6cHxBE8PLXrklLpFIPgBjAVklBphVREEvYUkgMNppy7XEMxKniGmEoyNrtjkAfCCH4k-hAa6xIq9jbyghGFpliCKQRC5oIKrsaAwMOhqiSJSqsUoBEpqXa0AP2sobBOl2LnfvdfI1rfY3aLsNUbU5q6iqgmeBskN1gqaplSND6aDyoKqKR64YwB8hqUJARSuFCgbZhdVR_QpUZ14ChpXbgbFqC6sB7qURkJCV0Ar6yprLwG50-IsiwRClcJpwRpa34igYsA-UHfBSP_KHERxxWGhdlj8VOLvVVWfJ5n_ZcjmQc5eAi9AHB4-W7oas9Mhn-fxy5z1ym3f3d8cEHpXKeiZIc6qgiXNLWZ46mA49smKe7MLcNfhcOHeteRURA5wEsMmbCIWo4BN8-sypUmgGwVcp1AC3PuLl77iBdSnVH8RxuMXg4HtFUIizh6n8IoyT1DA1H6vgThXDUJEJhVMk7N5VA2Y2e2TA6tE_MYppbM6eb81dBOfcrpVsNRutuZJbP7PN2-ri8Umd31y3e2MLZ3d457rrH3pPPvcXP_Tfvff7n1bg8uPL_Rzo32j32ivdjw-7a_c6bx73773ttB_0X3zrPn3UXVvubLzs3F_q3Fnv31rvPFnqLN78vrHx_etyr_2st7jae73YfXi3e_1V7_Ht3vN2b3V9pzdTr81Uj_luUxo_AZH4cRY1kiCNwPlP0qaiPG0oEWPWxZg1My5iiIBiuEgZiyaNOW8kScYTDnhhIw2yaJc33jrfynZ7k5ymcQoBXZxlkmaNStyopOBwgQvJ40jIYI-3rxDT7IU899As5wxzaEbRHo84wc26J9Ll2VHmsvcv8fZ5WxDO3y7v98bnL13JDkC8NR8ftIb2E1p9JcI
linkProvider CAB International
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%B6%B2%E7%9B%B8%E8%89%B2%E8%B0%B1-%E8%B4%A8%E8%B0%B1%EF%BC%8F%E8%B4%A8%E8%B0%B1%E8%81%94%E7%94%A8%E6%B3%95%E6%B5%8B%E5%AE%9A%E8%8B%AF%E5%94%91%E8%A5%BF%E6%9E%97%E6%B5%93%E5%BA%A6%E5%8F%8A%E5%85%B6%E8%83%B6%E5%9B%8A%E5%89%82%E4%BA%BA%E4%BD%93%E7%94%9F%E7%89%A9%E7%AD%89%E6%95%88%E6%80%A7%E7%9A%84%E7%A0%94%E7%A9%B6&rft.jtitle=%E4%B8%AD%E5%9B%BD%E5%8C%BB%E9%99%A2%E7%94%A8%E8%8D%AF%E8%AF%84%E4%BB%B7%E4%B8%8E%E5%88%86%E6%9E%90&rft.au=%E4%BB%BB%E8%BF%9B%E6%B0%91&rft.au=%E7%8E%8B%E5%B7%9D%E5%B9%B3&rft.au=%E8%B5%B5%E6%9B%A6&rft.au=%E8%91%A3%E5%8A%BC&rft.date=2015&rft.pub=%E6%B2%B3%E5%8C%97%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E7%AC%AC%E4%BA%8C%E5%8C%BB%E9%99%A2%E8%8D%AF%E5%AD%A6%E9%83%A8%2C%E6%B2%B3%E5%8C%97%E7%9F%B3%E5%AE%B6%E5%BA%84%2C050000%25%E7%9F%B3%E8%8D%AF%E9%9B%86%E5%9B%A2%E4%B8%AD%E5%A5%87%E5%88%B6%E8%8D%AF%E6%8A%80%E6%9C%AF+%E7%9F%B3%E5%AE%B6%E5%BA%84+%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8%2C%E6%B2%B3%E5%8C%97%E7%9F%B3%E5%AE%B6%E5%BA%84%2C050051&rft.issn=1672-2124&rft.issue=5&rft.spage=597&rft.epage=600&rft_id=info:doi/10.14009%2Fj.issn.1672-2124.2015.05.014&rft.externalDocID=zgyyyypjyfx201505014
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86765X%2F86765X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgyyyypjyfx%2Fzgyyyypjyfx.jpg